Hossein Jadvar and Patrick M. Colletti (Eds): Nuclear Medicine: the Essentials Luigi Mansi Book Review 21 June 2022 Pages: 3305 - 3305
Cervical lymph node staging in head and neck tumors: bridging the gap between humans and companion animals Lavinia Elena ChitiM. C. NolffD. Stefanello Editorial 05 May 2022 Pages: 3306 - 3308
2022 follow-up: impact of the COVID-19 pandemic on nuclear medicine departments in Europe Richard GrahamAna P. MoreiraFrançois Jamar Editorial 23 June 2022 Pages: 3309 - 3315
To give or not to give? A critical appraisal of a clinical trial on radioiodine treatment Murat TuncelAlexis VrachimisLuca Giovanella Editorial 18 May 2022 Pages: 3316 - 3319
Things are because we see them (O. Wilde): new radiopharmaceuticals for nuclear medicine imaging Martina SolliniRodolfo HurleMassimo Lazzeri Editorial 22 March 2022 Pages: 3320 - 3321
Total-body [18F]FDG PET/CT scan has stepped into the arena: the faster, the better. Is it always true? Luca FilippiOrazio Schillaci Editorial 09 April 2022 Pages: 3322 - 3327
EANM-EAU consensus on PSMA PET/CT in respect to radioligand therapy ([177Lu]Lu-PSMA) Stefano FantiJolanta KunikowskaAnders Bjartell Editorial 14 June 2022 Pages: 3328 - 3329
Construction and implementation of regional high-level PET alliance based on international consensus Jianshe YangZhongwei Lv Letter to the Editor 12 April 2022 Pages: 3330 - 3331
[177Lu]Lu-DOTATATE peptide receptor radionuclide therapy–associated myeloid neoplasms: insights from the WHO pharmacovigilance database Jonathan VigneBasile ChrétienCharles Dolladille Letter to the Editor 06 May 2022 Pages: 3332 - 3333
Letter to the editor David ZogalaVáclav PtáčníkMartin Šámal Letter to the Editor 28 May 2022 Pages: 3334 - 3335
Response to letter to the editor David KerstingMiriam SraiebChristoph Rischpler Letter to the Editor Open access 09 July 2022 Pages: 3336 - 3339
A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90: the TARGET study Marnix LamEtienne GarinRiad Salem Original Article Open access 08 April 2022 Pages: 3340 - 3352
EANM guideline on quality risk management for radiopharmaceuticals Nic GillingsOlaug HjelstuenAlmut Walte Guidelines Open access 07 April 2022 Pages: 3353 - 3364
[68 Ga]Ga-FAPI uptake correlates with the state of chronic kidney disease Patrick ConenFrancesca PennettaFelix M. Mottaghy Original Article Open access 06 January 2022 Pages: 3365 - 3372
First experiences with dynamic renal [68Ga]Ga-DOTA PET/CT: a comparison to renal scintigraphy and compartmental modelling to non-invasively estimate the glomerular filtration rate David KerstingMiriam SraiebChristoph Rischpler Original Article Open access 12 April 2022 Pages: 3373 - 3386
PET/CT-based radiomics of mass-forming intrahepatic cholangiocarcinoma improves prediction of pathology data and survival Francesco FizChiara MasciLuca Viganò Original Article 26 March 2022 Pages: 3387 - 3400
The “digital biopsy” in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT Lavinia MonacoElisabetta De BernardiLuca Guerra Original Article 11 April 2022 Pages: 3401 - 3411
Freely available artificial intelligence for pelvic lymph node metastases in PSMA PET-CT that performs on par with nuclear medicine physicians Elin TrägårdhOlof EnqvistLars Edenbrandt Original Article Open access 27 April 2022 Pages: 3412 - 3418
Lymphopenia in patients affected by SARS-CoV-2 infection is caused by margination of lymphocytes in large bowel: an [18F]FDG PET/CT study Alberto SignoreChiara LauriAntonio Aceti Original Article Open access 29 April 2022 Pages: 3419 - 3429
Evidence-based guideline of the European Association of Nuclear Medicine (EANM) on imaging infection in vascular grafts Chiara LauriAlberto SignoreNabil Chakfé Guidelines Open access 04 April 2022 Pages: 3430 - 3451
FDG-PET/CT in indeterminate thyroid nodules: cost-utility analysis alongside a randomised controlled trial Elizabeth J. de KosterDennis Vriensfor the EfFECTS trial study group Original Article Open access 18 April 2022 Pages: 3452 - 3469
The genetic duet of BRAF V600E and TERT promoter mutations predicts the poor curative effect of radioiodine therapy in papillary thyroid cancer Jingjia CaoXiaolu ZhuWei Zhang Original Article 02 May 2022 Pages: 3470 - 3481
Cortical abnormalities of synaptic vesicle protein 2A in focal cortical dysplasia type II identified in vivo with 18F-SynVesT-1 positron emission tomography imaging Yongxiang TangJie YuShuo Hu Original Article Open access 03 January 2022 Pages: 3482 - 3491
Quantitative assessment of myelin density using [11C]MeDAS PET in patients with multiple sclerosis: a first-in-human study Chris W. J. van der WeijdenJan F. MeilofErik F. J. de Vries Original Article Open access 02 April 2022 Pages: 3492 - 3507
Quantification of amyloid PET for future clinical use: a state-of-the-art review Hugh G. PembertonLyduine E. Collijon behalf of the AMYPAD consortium Review Article Open access 07 April 2022 Pages: 3508 - 3528
Efficacy and safety of 177Lu‑DOTATATE in patients with advanced pancreatic neuroendocrine tumours: data from the NETTER-R international, retrospective study Dominique ClementShaunak NavalkissoorJohn Ramage Original Article Open access 07 April 2022 Pages: 3529 - 3537
Diagnostic performance of total-body 18F-FDG PET/CT with fast 2-min acquisition for liver tumours: comparison with conventional PET/CT Yan HuGuobing LiuHongcheng Shi Original Article 28 March 2022 Pages: 3538 - 3546
Second primary malignancy risk in thyroid cancer and matched patients with and without radioiodine therapy analysis from the observational health data sciences and informatics Seok KimJi-In BangHo-Young Lee Original Article 01 April 2022 Pages: 3547 - 3556
Intraoperative MET-receptor targeted fluorescent imaging and spectroscopy for lymph node detection in papillary thyroid cancer: novel diagnostic tools for more selective central lymph node compartment dissection Pascal K. C. JonkerMadelon J. H. MetmanSchelto Kruijff Original Article Open access 07 April 2022 Pages: 3557 - 3570
Feasibility of [68Ga]Ga-FAPI-46 PET/CT for detection of nodal and hematogenous spread in high-grade urothelial carcinoma Lena M. UnterrainerSimon LindnerAlexander Kretschmer Original Article Open access 24 March 2022 Pages: 3571 - 3580
Hematologic toxicity profile and efficacy of [225Ac]Ac-PSMA-617 α-radioligand therapy of patients with extensive skeletal metastases of castration-resistant prostate cancer Ismaheel O. LawalAlfred MorgensternMike M. Sathekge Original Article 06 April 2022 Pages: 3581 - 3592
First-time imaging of [89Zr]trastuzumab in breast cancer using a long axial field-of-view PET/CT scanner Adrienne H. BrouwersJoyce van SluisCharalampos Tsoumpas Image of the Month Open access 01 April 2022 Pages: 3593 - 3595
225Ac-DOTATATE therapy in a case of metastatic pheochromocytoma Dengsai PengHanxiang LiuYue Chen Image of the Month 06 May 2022 Pages: 3596 - 3597
Correction to: An [18F]FDG‑PET/CT deep learning method for fully automated detection of pathological mediastinal lymph nodes in lung cancer patients David WallisMichaël SoussanIrène Buvat Correction Open access 31 May 2022 Pages: 3598 - 3598